184 related articles for article (PubMed ID: 29496562)
1. Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.
Buxbaum NP; Robinson C; Sinaii N; Ling A; Curtis LM; Pavletic SZ; Baird K; Lodish MB
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1415-1423. PubMed ID: 29496562
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.
Pirsl F; Curtis LM; Steinberg SM; Tella SH; Katić M; Dobbin M; Hsu J; Hakim FT; Mays JW; Im AP; Pulanić D; Mitchell SA; Baruffaldi J; Masuch L; Halverson DC; Gress RE; Barsony J; Pavletic SZ
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1517-1524. PubMed ID: 27118572
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
4. Bone Health Outcomes at 1 Year after Hematopoietic Stem Cell Transplantation in a Heterogeneous Pediatric Population.
Swauger S; Sabulski A; Hornung L; Wasserman H; Myers KC; Howell JC
Transplant Cell Ther; 2022 Jan; 28(1):44.e1-44.e6. PubMed ID: 34474165
[TBL] [Abstract][Full Text] [Related]
5. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
6. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
7. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
9. Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.
Curtis LM; Pirsl F; Steinberg SM; Mitchell SA; Baird K; Cowen EW; Mays J; Buxbaum NP; Pichard DC; Im A; Avila D; Taylor T; Fowler DH; Gress RE; Pavletic SZ
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1980-1988. PubMed ID: 28797782
[TBL] [Abstract][Full Text] [Related]
10. Effect of compression fracture on trabecular bone score at lumbar spine.
Hsu Y; Hsieh TJ; Ho CH; Lin CH; Chen CK
Osteoporos Int; 2021 May; 32(5):961-970. PubMed ID: 33104822
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor.
Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1655-1662. PubMed ID: 32504861
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
14. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.
van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJ; Pluijm SMF; Kremer LCM; Ronckers CM; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Olsson DS; Hoefer I; van den Berg SAA; den Hartogh J; Tissing WJE; Neggers SJCMM; van den Heuvel-Eibrink MM;
Lancet Diabetes Endocrinol; 2023 Jan; 11(1):21-32. PubMed ID: 36513116
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplantation thymic function is associated with the risk of acute graft versus host disease and cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.
Yang X; Sun Y; Zhang S; Yang H; Wei J; He Y; Yang D; Jiang E; Han M; Qin X; Feng S
Hematology; 2018 Jan; 23(1):30-37. PubMed ID: 28532344
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
Chen CT; Liu CY; Yu YB; Liu CJ; Hsiao LT; Gau JP; Chiou TJ; Liu JH; Liu YC
PLoS One; 2017; 12(9):e0185210. PubMed ID: 28934311
[TBL] [Abstract][Full Text] [Related]
18. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study.
Balduzzi A; Dalle JH; Wachowiak J; Yaniv I; Yesilipek A; Sedlacek P; Bierings M; Ifversen M; Sufliarska S; Kalwak K; Lankester A; Toporski J; Di Maio L; Glogova E; Poetschger U; Peters C
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2197-2210. PubMed ID: 31319153
[TBL] [Abstract][Full Text] [Related]
19. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
Lee SJ; Klein JP; Barrett AJ; Ringden O; Antin JH; Cahn JY; Carabasi MH; Gale RP; Giralt S; Hale GA; Ilhan O; McCarthy PL; Socie G; Verdonck LF; Weisdorf DJ; Horowitz MM
Blood; 2002 Jul; 100(2):406-14. PubMed ID: 12091329
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
